Adjusted Comparison of Daratumumab Monotherapy Versus Real-World Historical Control Data From The Czech Republic in Heavily Pre-Treated and Highly Refractory Multiple Myeloma Patients
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2090
https://www.valueinhealthjournal.com/article/S1098-3015(16)33456-8/fulltext
Title :
Adjusted Comparison of Daratumumab Monotherapy Versus Real-World Historical Control Data From The Czech Republic in Heavily Pre-Treated and Highly Refractory Multiple Myeloma Patients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33456-8&doi=10.1016/j.jval.2016.09.2090
First page :
A711
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1978